国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
氟哌噻吨美利曲辛治疗伴焦虑抑郁障碍的功能性胃肠病疗效观察
Effects of Flupentixol and Melitracen Tablets in the Treatment of Functional Gastrointestinal Disorders Combined with Anxiety or Depression
  
DOI:
中文关键词:  氟哌噻吨美利曲辛片  功能性胃肠病  疗效
英文关键词:Flupentixol and melitracen tablets  Functional gastrointestinal disorders  Efficacy
基金项目:
作者单位
尹宏伟 江山市中医院内科(浙江江山 324100) 
周慧芬 江山市中医院消化内科 
缪琪 辉瑞(北京)国际医学院临床药学研究中心 
摘要点击次数: 2097
全文下载次数: 1091
中文摘要:
      摘 要 目的:观察氟哌噻吨美利曲辛治疗伴焦虑抑郁障碍的功能性胃肠病患者的疗效与安全性。方法:65例伴焦虑抑郁障碍的功能性胃肠病患者随机分为两组,对照组30例给予常规治疗,观察组35例在常规治疗基础上加用氟哌噻吨美利曲辛片治疗。1个月后比较两组患者的消化道症状积分,HAMD评分、HAMA评分、临床疗效及药品不良反应等指标。结果:治疗后,两组患者的消化道症状积分、HAMD评分和HAMA评分均明显低于本组治疗前(P<0.05),且观察组各项评分明显低于对照组(P<0.05)。观察组的总有效率为94.29%,明显高于对照组的66.67%(P<0.001)。两组药品不良反应发生率比较,差异无统计学意义(P>0.05)。结论:氟哌噻吨美利曲辛片治疗伴焦虑抑郁障碍的功能性胃肠病,可有效缓解消化道症状,提高临床疗效,且安全性好,值得临床推广。
英文摘要:
      ABSTRACT Objective:To study the effect of flupentixol and melitracen tablets in the treatment of functional gastrointestinal disorders combined with anxiety or depression.Methods:65 patients with functional gastrointestinal disorders combined with anxiety or depression were randomly divided into the observation group(35 patients) and the control group(30 patients).The control group patients were treated by traditional treatment,,while the observation group patients were treated by traditional treatment, and flupentixol and melitracen tablets.After one month’s treatment, gastrointestinal symptom scores, HAMD scores and HAMA scores and treatment efficiency of two groups were statistical analyzed. Results: Gastrointestinal symptom score, HAMD score and HAMA score of two groups patients after treatment were lower than that before treatment(P<0.05).Besides,gastrointestinal symptom score, HAMD score and HAMA score of the observation group patients were lower than those of the control group(P<0.05).Treatment efficiency of the observation group patients(94.3%) were higher than that of the control group(66.7%)(P<0.001).There was no significant difference between the incidence of adverse drug reactions in two groups (P>0.05).Conclusion:The effects of flupentixol and melitracen tablets in the treatment of functional gastrointestinal disorders combined with anxiety or depression is good .So flupentixol and melitracen tablets can improve clinical outcomes and help patients recover. It's worthy of clinical promotion.
查看全文  查看/发表评论  下载PDF阅读器
关闭